COVID-19 weekly news: March 28-April 3 2022 - Insights
Topic's Include: Transplant, new model of care give hope to Salvadoran mom after cancer diagnosis, what you need to know about the COVID-19 BA.2 subvariant, and why calling the highly contagious COVID-19 omicron BA.2 a ‘stealth variant’ is...
Pathology consultation - Insights
Learn more about how Mayo Clinic Laboratories consultative pathology practice, which is supported by more than 100 board-certified pathologists, can provide expertise on any case.
September 2023 - Cytogenetics & Hematopathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Cytogenetics & Hematopathology.
While the diagnostic criteria of celiac disease are well defined, symptoms are generally nonspecific. This fact, combined with the variety of available tests — each with a specific utility and interpretation — can make a diagnosis...
Autoimmune neurology evolution - Insights
Patients with autoimmune neurologic conditions deserve the best chance at an accurate diagnosis. These answers can make a real difference in a patient’s treatment and quality of life.
Check out Mayo Clinic Laboratories’ expert-developed biochemical and molecular testing to confirm a diagnosis of oligosaccharidosis.
Learn about our sponsored testing program and how it can benefit both patients and healthcare providers.
Find out how our BioPharma Diagnostics capabilities can support your precision medicine initiatives, from discovery to post market.
Hereditary Colon Cancer Testing - Mayo Clinic Laboratories
Our algorithmic approach aids with the ordering process and guides physicians to ensure the right tests are being ordered at the right time for patients.
See how our comprehensive fluorescence in situ hybridization panels simplify the ordering process to ensure every patient receives the right test.